About NewLeaf Symbiotics
NewLeaf Symbiotics is a private company based in St. Louis, Missouri. It has reported $136,622,913 raised in ten offerings on Form D since August 2012.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 12, 2023 | Dec 21, 2023 | $47,006,248fully sold | 9 | $5.2M | EquityRule 506(b) | Form D ↗ |
| Dec 13, 2022 | Dec 23, 2022 | $6,745,000of $12.0M target | 4 | $1.6M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Dec 7, 2021 | Dec 13, 2021 | $10,000,000of $15.0M target | 5 | $2.0M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 14, 2020 | Feb 25, 2020 | $20,518,541of $35.0M target | 6 | $3.4M | EquityRule 506(b) | Form D ↗ |
| Dec 23, 2019 | Jan 8, 2020 | $2,000,000of $4.0M target | 1 | $2.0M | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 28, 2017 | Jul 10, 2017 | $23,827,046of $30.0M target | 15 | $1.5M | EquityRule 506(b) | Form D ↗ |
| Mar 14, 2017 | Mar 27, 2017 | $3,551,078fully sold | 9 | $394K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 12, 2014 | Sep 15, 2014 | $17,000,000fully sold | 16 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Jan 3, 2013 | Jan 18, 2013 | $4,800,000of $5.5M target | 4 | $1.2M | Equity, Options06 | Form D ↗ |
| Nov 3, 2011 | Aug 31, 2012amended Jan 8, 2013 | $1,175,000fully sold | 8 | $146K | Debt, Securities on exercise06 | Form D/A ↗1 earlier filing |
| Total, ten offerings | $136,622,913 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NewLeaf Symbiotics's Form D filed Dec 21, 2023.
Earlier filings also listed Desmond Jimenez (executive officer, last listed Dec 2022), Matt Helms (executive officer, last listed Dec 2021), Janne Kerovuo (executive officer, last listed Feb 2020), Thomas Laurita (executive officer and director, last listed Jan 2020), Stoddard Wilson (director, last listed Jan 2020), Michael McFatrich (executive officer, last listed Jan 2020), Doug Bryant (executive officer, last listed Jan 2020) and Todd Mockler (executive officer, last listed Sep 2014).